BeOne Medicines Ltd. — Director's Dealing 2018

Feb 13, 2018

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2017-12-31

Reporting Person: Glazer Donald W. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-31	Ordinary Shares	G	27287	—	Disposed	4538507	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	27287	Indirect

Footnotes

F1: This transaction involved a gift of 27,287 ordinary shares by the Reporting Person to his wife, who shares the Reporting Person's household. The Reporting Person disclaims beneficial ownership of the shares held by his wife, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his wife's shares for purposes of Section 16 or for any other purpose.